Ponatinib Hydrochloride
Brand name: Iclusig
Ponatinib Hydrochloride comes in 5 pill versions in our database, in 4 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Ponatinib Hydrochloride pill images
10 mg 1 pill
15 mg 2 pills
- A5 Ponatinib Hydrochloride 15 mg White, round, 6 mm Used for myeloid leukemia
- A5 Ponatinib Hydrochloride 15 mg White, round, 6 mm Used for myeloid leukemia
30 mg 1 pill
45 mg 1 pill
What is Ponatinib Hydrochloride used for?
Ponatinib Hydrochloride is used for myeloid leukemia.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
ICLUSIG® is indicated for the treatment of adult patients with:
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
- Newly diagnosed Ph+ ALL in combination with chemotherapy. This indication is approved under accelerated approval based on minimal residual disease (MRD)-negative complete remission (CR) at the end of induction. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).
- As monotherapy in Ph+ ALL for whom no other kinase inhibitors are indicated or T315I-positive Ph+ ALL.
Chronic Myeloid Leukemia (CML)
- Chronic phase (CP) CML with resistance or intolerance to at least two prior kinase inhibitors.
- Accelerated phase (AP) or blast phase (BP) CML for whom no other kinase inhibitors are indicated.
- T315I-positive CML (chronic phase, accelerated phase, or blast phase).
Limitations of Use: ICLUSIG is not indicated and is not recommended for the treatment of patients with newly diagnosed CP-CML.
From the FDA-approved label on DailyMed (published Aug 19, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.